Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published:November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like Sensory cues from the opposite sex affect aging in animals February 28, 2024 Study reveals how maternal diabetes affects birth defects at the single-cell level December 4, 2023 Unveiling the brain mechanism behind memory consolidation in sleep March 28, 2024